Effects of Vitamin D Supplementation on Antimycobacterial Immunity

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine how vitamin D supplementation (ergocalciferol) affects the immune response to mycobacterial infection.

• Phase: N/A

Details

• Lead Sponsor: Barts & The London NHS Trust
• Collaborators: Department of Clinical Biochemistry, Homerton Hospital, London E9 6SR, UK; Environmental Health Department, London Borough of Newham, London E15 4SF, UK; Imperial College London; Newham Chest Clinic, London E7 8QP, UK; Northwick Park Hospital, Harrow, UK; University of Cape Town; Wellcome Trust
• Treatments: Anti-Bacterial Agents; Ergocalciferols; Vitamin D

Criteria

Inclusion Criteria:

• Adult

• Tuberculosis (TB) contact or TB patient

Exclusion Criteria:

• Pregnancy

• Breastfeeding

• Hyperparathyroidism

• Sarcoidosis

• Renal failure

• HIV infection